Cardiac dysfunction and inefficiency after substrate-enriched warm blood cardioplegia

European Journal of Cardio-thoracic Surgery

Volumn 20, Issue 3, 2001, Pages 555-564

  Korvald, Christian ^a   Elvenes, Odd P ^a   Myrmel, Truls ^a   Sorlie, Dag G ^a  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

Author keywords

GIK; Glutamine; Left ventricle; Mechanoenergetic efficiency; Warm blood cardioplegia

Indexed keywords

CARDIOPLEGIC AGENT; GLUCOSE; GLUTAMINE; INSULIN;

ANIMAL MODEL; ARTICLE; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY PRESSURE; DIASTOLIC BLOOD PRESSURE; ENERGY CONSUMPTION; ENERGY TRANSFER; FEMALE; HEART DISEASE; HEART LEFT VENTRICLE PRESSURE; HEART PRELOAD; MALE; NONHUMAN; PRIORITY JOURNAL; SWINE; TECHNIQUE; TEMPERATURE; TREATMENT OUTCOME;

EID: 0034908769     PISSN: 10107940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1010-7940(01)00849-1     Document Type: Article

References (46)

1. Randomized trial of normothermic versus hypothermic coronary bypass surgery
2. Prospective, randomized trial of retrograde warm blood cardioplegia: myocardial benefit and neurologic threat
3. Normothermic continuous antegrade blood cardioplegia does not prevent myocardial oedema and cardiac dysfunction
4. Polarization and myocardial protection
5. Myocardial 'stunning' in man
6. Myocardial substrate oxidation during warm continuous blood cardioplegia
7. Myocardial metabolism and efficiency after warm continuous blood cardioplegia
8. Myocardial substrate metabolism influences left ventricular energetics in vivo
9. Myocardial energy replenishment and reversal of ischemic damage by substrate enhancement of secondary blood cardioplegia with amino acids during reperfusion
10. Rationale for metabolic support with amino acids and glucose-insulin-potassium (GIK) in cardiac surgery
11. Effects of glutamate and aspartate on myocardial substrate oxidation during potassium arrest
12. Glucose for the heart
13. Left ventricular stroke volume by single and dual excitation of conductance catheter in dogs
14. Ventricular energetics
15. Quantification of regional myocardial dysfunction after acute ischemic injury
16. Ventriculo-arterial coupling: concepts, assumptions, and applications
17. Molecular and cellular mechanisms of myocardial stunning
18. Iatrogenic myocardial oedema: increased diastolic compliance and time course of resolution in vivo
19. The influence of myocardial oedema formation on the energy consumption of the heart during aerobiosis and hypoxia
20. Protective effect of increased glycolytic substrate against systolic and diastolic dysfunction and increased coronary resistance from prolonged global underperfusion and reperfusion in isolated rabbit hearts perfused with erythrocyte suspensions
21. Retrograde cardioplegia
22. Increasing the colloid osmotic pressure of cardiopulmonary bypass prime and normothermic blood cardioplegia minimizes myocardial oedema and prevents cardiac dysfunction
23. Determinants of a protective effect of glucose and insulin on the ischemic myocardium. Effects on contractile function, diastolic compliance, metabolism, and ultrastructure during ischemia and reperfusion
24. Normothermic versus hypothermic hyperkalemic cardioplegia: effects on myocyte contractility
25. Myocardial protection with high-dose β-blockade in acute myocardial ischemia
26. Cardiac dysfunction and inefficiency after substrate enriched warm blood cardioplegia
27. Early changes in regional and global left ventricular function after aortic valve replacement. Comparison of crystalloid, cold blood, and warm blood cardioplegias
28. Randomised trial of normothermic versus hypothermic coronary bypass surgery
29. Unloaded heart in vivo replicates fetal gene expression of cardiac hypertrophy
30. Regulation of alpha-smooth muscle actin expression in adult cardiomyocytes through a tyrosine kinase signal transduction pathway
31. Energy metabolism of the heart: From basic concepts to clinical applications
32. Cardiac efficiency is improved after ischemia by altering both the source and fate of protons
33. Structural and metabolic correlates of the reversibility of chronic left ventricular ischemic dysfunction in humans
34. Studies of myocardial protection in the immature heart. IV. Improved tolerance of immature myocardium to hypoxia and ischemia by intravenous metabolic support
35. Myocardial uptake of amino acids and other substrates in relation to myocardial oxygen consumption four hours after cardiac operations
36. Glutamate and high dose glucose-insulin-potassium (GIK) in the treatment of severe cardiac failure after cardiac operations
37. Protection of ischemic rabbit myocardium by glutamic acid
38. Improved cardiac function with glucose-insulin-potassium after coronary bypass surgery
39. Is there a rationale for glucose-insulin-potassium therapy in acute myocardial infarction?
40. Warm glutamate/aspartate-enriched blood cardioplegic solution for perioperative sudden death
41. Altered metabolite exchange between subcellular compartments in intact postischemic rabbit hearts
42. Role of amino acids and enhancement cardioplegia in routine myocardial protection. Experimental results
43. Resuscitative retrograde blood cardioplegia. Are amino acids or continous warm techniques necessary?
44. Insulin improves functional and metabolic recovery of reperfused working rat heart
45. 2+-ATPases in muscle and heart
46. The effect of insulin cardioplegia on atrial fibrillation after high-risk coronary bypass surgery: a double-blinded, randomized, controlled trial